SCHEMBL7016433

SCHEMBL7016433

N#CC=Cc1ccc(F)cc1C(F)(F)F

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
APP P05067 1/20 0.39
KCNH2 Q12809 1/20 0.37
IDO1 P14902 2/20 0.37
AR P10275 1/20 0.35
HCAR1 Q9BXC0 1/20 0.34
NFE2L2 Q16236 2/20 0.33
MAOB P27338 1/20 0.33
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
GAA P10253 1/20 0.33
MAPT P10636 1/20 0.33
HTT P42858 1/20 0.33
KMT2A Q03164 1/20 0.33
CYP1A1 P04798 1/20 0.33
CYP1B1 Q16678 1/20 0.33
PTGES2 Q9H7Z7 2/20 0.33
KIF11 P52732 1/20 0.33
SLC6A2 P23975 1/20 0.32
SLC6A4 P31645 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7016426 1.00 APP (0.39) APPKCNH2IDO1ARHCAR1
SCHEMBL13989035 1.00 APP (0.39) APPKCNH2IDO1ARHCAR1
SCHEMBL5644762 0.77 NFKB1 (0.53) MAOBMAPTKMT2A
SCHEMBL29110157 0.77 APP (0.42) APPKCNH2IDO1HCAR1NFE2L2
SCHEMBL4728560 0.77 NFKB1 (0.53) MAOBMAPTKMT2A
SCHEMBL30619993 0.77 APP (0.42) APPKCNH2IDO1HCAR1NFE2L2
SCHEMBL17489479 0.77 APP (0.42) APPKCNH2IDO1HCAR1NFE2L2
SCHEMBL9651833 0.75 PTGS1 (0.39) KCNH2HCAR1NFE2L2KDM4E
SCHEMBL9869836 0.75 PTGS1 (0.39) KCNH2HCAR1NFE2L2KDM4E
SCHEMBL7480445 0.75 MAOA (0.42) KCNH2NFE2L2MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7462620-B2 Pyrimidinone derivatives and their use in the treatment of atherosclerosis SMITHKLINE BEECHAM, PLC (GB) 2008-12-09 US disclosed
US-7169924-B2 Pyrimidinone derivatives and their use in the treatment of atherosclerosis SMITHKLINE BEECHAM PLC (GB) 2007-01-30 US disclosed
EP-1337517-A1 PYRIMIDINONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF ATHEROSCLEROSIS SMITHKLINE BEECHAM PLC (GB) 2003-08-27 EP disclosed
WO-2002030911-A1 PYRIMIDINONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF ATHEROSCLEROSIS SMITHKLINE BEECHAM P.L.C. (GB) 2002-04-18 WO disclosed